Transforming growth factor beta-activated kinase 1 (TAK1) kinase adaptor, TAK1-binding protein 2, plays dual roles in TAK1 signaling by recruiting both an activator and an inhibitor of TAK1 kinase in tumor necrosis factor signaling pathway.
about
The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammationTGF-β signaling via TAK1 pathway: role in kidney fibrosisTAK1 binding protein 2 is essential for liver protection from stressorsA Novel Functional Domain of Tab2 Involved in the Interaction with Estrogen Receptor Alpha in Breast Cancer CellsFunctions of protein phosphatase-6 in NF-κB signaling and in lymphocytes.Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis.TAK1 control of cell death.Tumor necrosis factor receptor-associated factor (TRAF) 2 controls homeostasis of the colon to prevent spontaneous development of murine inflammatory bowel disease.Roles of the kinase TAK1 in CD40-mediated effects on vascular oxidative stress and neointima formation after vascular injury.Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA [corrected].Adaptation of HepG2 cells to a steady-state reduction in the content of protein phosphatase 6 (PP6) catalytic subunitEpithelial transforming growth factor β-activated kinase 1 (TAK1) is activated through two independent mechanisms and regulates reactive oxygen speciesProtection from cerebral ischemia by inhibition of TGFβ-activated kinaseTGF-β-activated kinase-1: New insights into the mechanism of TGF-β signaling and kidney disease.Novel Ser/Thr protein phosphatases in cell death regulationMiR674 inhibits the neuraminidase-stimulated immune response on dendritic cells via down-regulated Mbnl3.TAK1 kinase switches cell fate from apoptosis to necrosis following TNF stimulation.The TGFβ1 pathway is required for NFκB dependent gene expression in mouse keratinocytes.TAK1, more than just innate immunity.TAK1 regulates hepatic cell survival and carcinogenesis.TAK1 selective inhibition: state of the art and future opportunities.Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells.Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis.TAK-1/p38/nNFκB signaling inhibits myoblast differentiation by increasing levels of Activin A.Molecular changes associated with increased TNF-α-induced apoptotis in naïve (TN) and central memory (TCM) CD8+ T cells in aged humans.Diet-Induced Obesity and the Mechanism of Leptin Resistance.A novel MAP3K7 splice mutation causes cardiospondylocarpofacial syndrome with features of hereditary connective tissue disorder.
P2860
Q24296068-7857EA3B-4824-4DEF-BA36-D8E52184E967Q26824337-90DC0DE2-84A9-46AA-87B5-864DA6530260Q28539471-A2DD3600-E4A4-41B0-9C17-0C65F86BECABQ28555115-4A18CAAA-3901-404A-A692-C026DAA66C98Q33805622-2D32167C-897D-4F93-BE66-F1F73E6B8B69Q34059345-C4218970-3105-4643-8D07-DFFE2EF8A91DQ34413437-F160DB37-FD87-4FEF-938C-FF9D40FCE470Q34979007-692198A4-09AA-4FB5-922F-646A9754E717Q35210912-B1A0B367-11E7-47FA-A71B-5730C2169576Q35574768-4490FBD4-E9BF-41F1-A813-4D74BE14A91EQ35798066-31B503EC-4C55-4DCE-B867-AD0F2A4EBF96Q35807430-E65B29FF-FFC2-437C-A16F-C2242232826FQ36162153-A669A0C8-1B5B-4624-8632-6403631F4F8BQ36468657-AFE15A19-BA8D-4981-AD61-3D227BDEABDCQ37256583-C5A203A1-80B7-41EB-94D2-2EE3A0796D44Q37580153-1BCE6CE0-1772-4358-BC8B-960B17047A8EQ37589371-02B35E6A-87F3-4724-B807-14B2D2C2519DQ37617570-AF219DD2-7738-405A-9FE6-DD189EA36B1FQ38040025-D607DE5D-C6BE-47E6-BED3-DF8EBDDA8BE0Q38180064-3CB2B38E-B120-485F-BDF0-2D5C4EDBABACQ38315867-1213342D-DBE1-46CF-8C53-054AFC06A434Q39411427-B7EE3D80-8036-4AF8-91DA-45FD5CA28BC9Q41527499-2C5FB233-63F8-4D6C-BFC8-2048EF71D4D3Q42117099-C244F6ED-96C9-4693-986A-ED182DDD688AQ49424017-CCD13B79-5352-45B6-BBF0-319EEDE422FEQ50957776-C2D2E998-BC76-4FE7-8315-0E1BE08A6E57Q52691549-E6DA1EA2-21E4-45FA-BD0F-60DE3BB669C6
P2860
Transforming growth factor beta-activated kinase 1 (TAK1) kinase adaptor, TAK1-binding protein 2, plays dual roles in TAK1 signaling by recruiting both an activator and an inhibitor of TAK1 kinase in tumor necrosis factor signaling pathway.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Transforming growth factor bet ...... osis factor signaling pathway.
@ast
Transforming growth factor bet ...... osis factor signaling pathway.
@en
type
label
Transforming growth factor bet ...... osis factor signaling pathway.
@ast
Transforming growth factor bet ...... osis factor signaling pathway.
@en
prefLabel
Transforming growth factor bet ...... osis factor signaling pathway.
@ast
Transforming growth factor bet ...... osis factor signaling pathway.
@en
P2093
P2860
P356
P1476
Transforming growth factor bet ...... osis factor signaling pathway.
@en
P2093
David L Brautigan
Kunihiro Matsumoto
Peter Broglie
Shizuo Akira
P2860
P304
P356
10.1074/JBC.M109.090522
P407
P577
2009-12-02T00:00:00Z